Vanilloid receptor 6 (VANILREP6) polypeptides and polynucleotides and methods for producing these ion channels by recombinant techniques are disclosed. Also disclosed are methods for utilising VANILREP6 polynucleotides and polypeptides in pharmacological assays. Splice variants of VANILREP6 are also disclosed. Such peptides may be of use in the treatment of disorders including pain, neurological disorders, inflammatory disorders, ischemia, neurodegeneration and inflammatory bowl disease.
Vanilloid Receptor 6